Clinical trials data
Trail Making Test in pain and fatigue trials: 94 registered studies
Every registered pain and fatigue study on ClinicalTrials.gov that names the Trail Making Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered pain and fatigue studies name it in an outcome measure
- 94
- Name it in a primary outcome, 29%
- 27 of 94
Tests named in the same studies
- 1
Stroop Color-Word Test26 studies, 11 as a primary outcome
- 2
Digit Span Test25 studies, 13 as a primary outcome
- 3
Verbal Learning21 studies, 4 as a primary outcome
- 4
Verbal Fluency18 studies, 6 as a primary outcome
- 5
Symbol Coding13 studies, 5 as a primary outcome
- 6
Task Switching Test7 studies, 1 as a primary outcome
- 7
Paced Visual Serial Addition Test6 studies, 2 as a primary outcome
- 8
Category Fluency5 studies, 1 as a primary outcome
- 9
Complex Figure Copy and Recall4 studies, 1 as a primary outcome
- 10
Continuous Performance Test4 studies, 1 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 2 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 1 | 1 |
| 2010 | 2 | 1 |
| 2011 | 2 | 0 |
| 2012 | 3 | 0 |
| 2013 | 4 | 1 |
| 2014 | 1 | 0 |
| 2015 | 1 | 1 |
| 2016 | 3 | 0 |
| 2017 | 8 | 1 |
| 2018 | 6 | 1 |
| 2019 | 3 | 0 |
| 2020 | 7 | 3 |
| 2021 | 6 | 2 |
| 2022 | 6 | 2 |
| 2023 | 7 | 5 |
| 2024 | 9 | 4 |
| 2025 | 10 | 2 |
| 2026 | 9 | 2 |
Phases and study sizes
By phase
- Early phase 12 studies, 0 as a primary outcome
- Phase 11 studies, 0 as a primary outcome
- Phase 1/22 studies, 0 as a primary outcome
- Phase 212 studies, 1 as a primary outcome
- Phase 34 studies, 3 as a primary outcome
- Phase 42 studies, 0 as a primary outcome
- Not applicable52 studies, 16 as a primary outcome
- Observational19 studies, 7 as a primary outcome
Participants per study
- Phase 2100 median, 49 to 104
- Not applicable61 median, 31 to 111
- Observational91 median, 53 to 103
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 10 | 100 | 49 to 104 |
| Not applicable | 50 | 61 | 31 to 111 |
| Observational | 18 | 91 | 53 to 103 |
When pain and fatigue trials measure it
Latest time point of each outcome
- Within a day11 outcomes, 2 as a primary outcome
- Up to 4 weeks17 outcomes, 6 as a primary outcome
- 1 to 3 months30 outcomes, 8 as a primary outcome
- 3 to 6 months8 outcomes, 2 as a primary outcome
- 6 to 12 months12 outcomes, 3 as a primary outcome
- 1 to 2 years2 outcomes, 2 as a primary outcome
- Over 2 years2 outcomes, 1 as a primary outcome
- No duration given12 outcomes, 3 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
82 of the 94 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting16 studies, 2 as a primary outcome
- Not yet recruiting7 studies, 2 as a primary outcome
- Active, not recruiting2 studies, 1 as a primary outcome
- Completed45 studies, 14 as a primary outcome
- Stopped early8 studies, 2 as a primary outcome
- Status unknown16 studies, 6 as a primary outcome
What they test
- Behavioral11 studies, 3 as a primary outcome
- Drug27 studies, 4 as a primary outcome
- Device19 studies, 6 as a primary outcome
- Dietary supplement3 studies, 0 as a primary outcome
- Procedure6 studies, 2 as a primary outcome
- Diagnostic test3 studies, 2 as a primary outcome
- Radiation1 studies, 1 as a primary outcome
- Other29 studies, 7 as a primary outcome
- None given9 studies, 4 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States34 studies, 9 as a primary outcome
- France8 studies, 0 as a primary outcome
- Türkiye6 studies, 2 as a primary outcome
- Brazil5 studies, 2 as a primary outcome
- China5 studies, 2 as a primary outcome
- Italy5 studies, 2 as a primary outcome
- Germany4 studies, 1 as a primary outcome
- Canada3 studies, 0 as a primary outcome
- Norway3 studies, 0 as a primary outcome
- Spain3 studies, 0 as a primary outcome
- Denmark2 studies, 1 as a primary outcome
- Austria1 studies, 0 as a primary outcome
21 countries in all. A study with sites in several counts in each; 6 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed pain and fatigue studies that name the Trail Making Test: 20 of 45, 44%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed pain and fatigue studies that name the Trail Making Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 1, 2% | 776, 10% |
| Results on ClinicalTrials.gov only | 5, 11% | 1,139, 14% |
| A results paper only | 14, 31% | 1,711, 22% |
| Neither | 25, 56% | 4,327, 54% |
The 94 studies
94 studies match. 27 name the Trail Making Test in a primary outcome. Median size 72 participants. Median time to the primary outcome: 9 weeks.
Loading 94 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 1 planned to start after 2026.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 2 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 1 | 1 |
| 2010 | 2 | 1 |
| 2011 | 2 | 0 |
| 2012 | 3 | 0 |
| 2013 | 4 | 1 |
| 2014 | 1 | 0 |
| 2015 | 1 | 1 |
| 2016 | 3 | 0 |
| 2017 | 8 | 1 |
| 2018 | 6 | 1 |
| 2019 | 3 | 0 |
| 2020 | 7 | 3 |
| 2021 | 6 | 2 |
| 2022 | 6 | 2 |
| 2023 | 7 | 5 |
| 2024 | 9 | 4 |
| 2025 | 10 | 2 |
| 2026 | 9 | 2 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 3, other 91. Interventional 75, observational 19.
As a primary outcomeSecondary or other outcomeThe Trail Making Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07906847 | Start2026 | PhaseObservational | ConditionsPain and fatigue | Participants80 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07851896 | Start2026 | PhaseNot applicable | ConditionsPain and fatigue | Participants40 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07842302 | Start2026 | PhaseNot applicable | ConditionsMultiple sclerosis, Pain and fatigue | Participants80 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07766980 | Start2026 | PhasePhase 2 | ConditionsPain and fatigue | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07641335 | Start2026 | PhaseNot applicable | ConditionsPain and fatigue | Participants12 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07624084 | Start2025 | PhaseNot applicable | ConditionsPain and fatigue | Participants42 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07539116 | Start2024 | PhaseNot applicable | ConditionsPain and fatigue | Participants183 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07477483 | Start2025 | PhaseNot applicable | ConditionsPain and fatigue | Participants50 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07432425 | Start2025 | PhaseNot applicable | ConditionsPain and fatigue | Participants21 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07429903 | Start2023 | PhaseNot applicable | ConditionsCOVID-19 and long COVID, Pain and fatigue | Participants31 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07393672 | Start2026 | PhasePhase 2 | ConditionsAnxiety, PTSD and OCD, Pain and fatigue | Participants104 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07357688 | Start2026 | PhaseNot applicable | ConditionsPain and fatigue | Participants99 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07203339 | Start2025 | PhaseNot applicable | ConditionsPain and fatigue | Participants610 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07141550 | Start2026 | PhaseNot applicable | ConditionsPain and fatigue | Participants30 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06967363 | Start2025 | PhaseObservational | ConditionsSleep and sleep disorders, Pain and fatigue | Participants360 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06945848 | Start2026 | PhaseNot applicable | ConditionsCancer, Pain and fatigue, Cardiovascular disease | Participants114 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06940063 | Start2025 | PhaseNot applicable | ConditionsPain and fatigue | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06919744 | Start2025 | PhaseNot applicable | ConditionsCancer, Pain and fatigue, Cardiovascular disease | Participants114 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06837857 | Start2025 | PhasePhase 2 | ConditionsPain and fatigue | Participants200 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06834685 | Start2025 | PhaseNot applicable | ConditionsCancer, Pain and fatigue | Participants70 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06831916 | Start2025 | PhasePhase 2 | ConditionsAnxiety, PTSD and OCD, Pain and fatigue | Participants104 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06711731 | Start2024 | PhaseObservational | ConditionsPain and fatigue | Participants2,000 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06706479 | Start2024 | PhaseNot applicable | ConditionsPain and fatigue | Participants48 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06614309 | Start2024 | PhaseNot applicable | ConditionsCOVID-19 and long COVID, Pain and fatigue | Participants45 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06609343 | Start2027 | PhasePhase 1/2 | ConditionsPain and fatigue | Participants16 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
Questions, answered from the data
How many pain and fatigue trials use the Trail Making Test?
94 registered pain and fatigue studies on ClinicalTrials.gov name it in an outcome measure, 27 of them in a primary outcome: 14% of the condition's 681 studies with a cognitive outcome, against 14% of all of them. It is the 2nd most named test in pain and fatigue trials.
Which tests do pain and fatigue trials use with the Trail Making Test?
The Stroop Color-Word Test (26 studies), the Digit Span Test (25 studies) and Verbal Learning (21 studies).
How many participants do phase 2 pain and fatigue trials that use the Trail Making Test enroll?
Half of the phase 2 studies that name it enroll 100 participants or fewer, and the middle half enroll 49 to 104. 10 of them give a size.
When do pain and fatigue trials measure the Trail Making Test?
Half of the primary outcomes that name the Trail Making Test are measured within 9 weeks of the start, and the middle half from 3 weeks to 7 months. 24 primary outcomes give a duration.
How many completed pain and fatigue trials that use the Trail Making Test have reported results?
20 of the 45 completed studies that name it, 44%, have reported results: 6 posted them on ClinicalTrials.gov, 15 have a results paper linked to the registry record, and 1 did both. The other 25 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Trail Making Test A and Trail Making Test B as one test family, so this page counts their studies together.
Run the Trail Making Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.